TongliBio announces to receive an early investment from two private investment groups including TF capital
Time:2017-04-05

TongliBio announces to receive an early investment from two private investment groups including TF capital. The funds will support for IND submission to US FDA and CMC preparation of TL-010 API and tablets for cllinical developement, as well as ongoing preclinical-stage projects.